The device is designed to facilitate safe and reproducible left-heart access. Credit: MMD Creative / Shutterstock.com. Protaryx Medical has received the US Food and Drug Administration (FDA) 510(k) ...

Avanos Medical is to be acquired by affiliates of AIP in an all-cash transaction that values the company at an enterprise value of $1.27bn.

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.

J&J has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its Varipulse PFA platform in first-time users.

ProSomnus Sleep Technologies has received the US Food and Drug Administration (FDA) Class II 510(k) clearance for its RPMO₂ OSA device.

Heartflow alleges that after working as its consultant, Cleerly’s CEO launched a competing enterprise “built upon” Heartflow’s innovations.

Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.

Click's CT-155 commercialisation plan comes as regulatory-approved digital therapeutics experience strong market growth.

The MHRA has secured a $4.8m funding increase over three years to expand the AI Airlock programme, the UK’s regulatory sandbox for AIaMD.

GE HealthCare has integrated its bkActiv iUS system with Medtronic's Stealth AXiS system to provide imaging during cranial procedures.

Linked to high mortality rates, current treatment options for tricuspid regurgitation remain extremely limited.

CorTec's BCI aims to differentiate itself by offering brain-based communication alongside therapeutic neurostimulation.